These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7142369

  • 1. Human IgA antibody and immunoglobulin production after in vivo tetanus toxoid immunization: size and surface membrane phenotype analysis.
    Thiele CJ, Morrow CD, Stevens RH.
    J Clin Immunol; 1982 Oct; 2(4):327-34. PubMed ID: 7142369
    [Abstract] [Full Text] [Related]

  • 2. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H, Gale RP, Saxon A.
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH, Saxon A.
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [Abstract] [Full Text] [Related]

  • 7. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
    Saiki O, Ralph P.
    Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity.
    Thiele CJ, Morrow CD, Stevens RH.
    J Immunol; 1981 Mar; 126(3):1146-53. PubMed ID: 6970218
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells.
    Conley ME, Bartelt MS.
    J Immunol; 1984 Nov; 133(5):2312-6. PubMed ID: 6332844
    [Abstract] [Full Text] [Related]

  • 14. A restricted component of T cell help in pokeweed mitogen-stimulated humans peripheral blood cell cultures.
    Macy E, Stevens RH.
    J Immunol; 1980 Feb; 124(2):752-9. PubMed ID: 6965390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro humoral immune response of human peripheral blood lymphocytes to tetanus toxoid sepharose 4B.
    Khansari N, Fudenberg HH, Merler E.
    Immunobiology; 1983 Feb; 164(1):42-50. PubMed ID: 6852857
    [Abstract] [Full Text] [Related]

  • 17. Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.
    Stevens RH, Saxon A.
    Cell Immunol; 1979 Jun; 45(1):142-50. PubMed ID: 455480
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response to mucosal antigen challenge in IgA nephropathy.
    Layward L, Allen AC, Hattersley JM, Harper SJ, Feehally J.
    Exp Nephrol; 1995 Jun; 3(5):300-7. PubMed ID: 7583052
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulin-bearing cells are a target for the antigen-induced inhibition of pokeweed mitogen-stimulated antibody production.
    Stevens RH.
    J Immunol; 1981 Sep; 127(3):968-72. PubMed ID: 6973587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.